Differential expression of osteoblast and osteoclast markers by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34).

被引：0
|
作者：
Chiou, SS [1 ]
Avnur, Z [1 ]
Vickery, BH [1 ]
Cannon, PD [1 ]
机构：
[1] ROCHE BIOSCI,OSTEOPOROSIS & ENDOCRINE RES,PALO ALTO,CA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1997年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：T445 / T445
页数：1
相关论文
共 50 条
  • [41] The hydrophobic residues phenylalanine 184 and Leucine 187 in the type-1 parathyroid hormone (PTH) receptor functionally interact with the amino-terminal portion of PTH-(1-34)
    Carter, Percy H.
    Shimizu, Masaru
    Luck, Michael D.
    Gardella, Thomas J.
    Journal of Biological Chemistry, 274 (45): : 31955 - 31960
  • [42] MONOCLONAL-ANTIBODY AGAINST 1-34 PTH PEPTIDE BINDS OSTEOCLAST ACTIVATING FACTOR (OAF)
    OFFENBACHER, S
    STASHENKO, P
    BINDER, TA
    GOODSON, JM
    JOURNAL OF DENTAL RESEARCH, 1981, 60 : 498 - 498
  • [43] Interactions between the mid-region of PTH-(1-34) and the receptor orient the hormone for receptor activation.
    Wittelsberger, A
    Corich, M
    Lee, B
    Barazza, A
    Yacobi, R
    Czodrowski, P
    Mierke, DF
    Alexander, JM
    Rosenblatt, M
    Chorev, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S101 - S101
  • [44] DIFFERENCE IN RENAL TUBULAR TRANSPORT EFFECTS OF 1-34 AND 1-84 PARATHYROID-HORMONE (PTH)
    PUSCHETT, JB
    MCGOWAN, J
    FRAGOLA, J
    CHEN, TC
    ROSENBLATT, M
    KEUTMANN, H
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1982, 151 : 81 - 82
  • [45] DIFFERING EFFECTS OF 1-34 AND 1-84 PARATHYROID-HORMONE (PTH) ON RENAL TUBULAR TRANSPORT
    MCGOWAN, J
    FRAGOLA, J
    CHEN, TC
    ROSENBLATT, M
    KEUTMANN, H
    PUSCHETT, JB
    CLINICAL RESEARCH, 1981, 29 (02): : A471 - A471
  • [46] CA-2+ CONCENTRATION INFLUENCES THE HEPATIC EXTRACTION OF BIOACTIVE HUMAN PTH-(1-34) IN RATS
    DAMOUR, P
    HUET, PM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01): : E87 - E92
  • [47] In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis
    Williams, Allan J.
    Jordan, Faron
    King, Gareth
    Lewis, Andrew L.
    Illum, Lisbeth
    Masud, Tahir
    Perkins, Alan C.
    Pearson, Richard G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 535 (1-2) : 113 - 119
  • [48] Prevention of Atrophic Nonunion by the Systemic Administration of Parathyroid Hormone (PTH 1-34) in an Experimental Animal Model
    Lin, Edward A.
    Liu, Chuan-Ju
    Monroy, Alexa
    Khurana, Sonya
    Egol, Kenneth A.
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2012, 26 (12) : 719 - 723
  • [49] Parathyroid hormone (1-34) augments angiopoietin-1 expression in human osteoblast-like cells
    Park, J. H.
    Song, H. I.
    Rho, J. M.
    Kim, M. R.
    Kim, J. R.
    Park, B. H.
    Park, T. S.
    Baek, H. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (08) : 438 - 443
  • [50] Parathyroid hormone-related peptide-(1-34) [PTHrP-(1-34)] induces vasopressin release from the rat supraoptic nucleus in vitro through a novel receptor distinct from a type I or type II PTH/PTHrP receptor
    Yamamoto, S
    Morimoto, I
    Yanagihara, N
    Zeki, K
    Fujihira, T
    Izumi, F
    Yamashita, H
    Eto, S
    ENDOCRINOLOGY, 1997, 138 (05) : 2066 - 2072
12345